Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09331 | 31788461 | Front Pediatr | Progressive Liver Disease in Patients With Ataxia Telangiectasia. | 2019 | Details |
| A09332 | 31788011 | Nutr Metab (Lond) | Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE-/- mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. | 2019 | Details |
| A09333 | 31787541 | Ann Hepatol | The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy. | 2019 | Details |
| A09335 | 31786361 | Diabetes Metab | Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. | 2019 | Details |
| A09336 | 31786360 | Diabetes Metab | Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD. | 2019 | Details |
| A09337 | 31786336 | Biochim Biophys Acta Mol Basis Dis | Protective effect of metformin against palmitate-induced hepatic cell death. | 2019 | Details |
| A09338 | 31786271 | Physiol Behav | Modulation of hippocampal TLR4/BDNF signal pathway using probiotics is a step closer towards treating cognitive impairment in NASH model. | 2019 | Details |
| A09339 | 31785600 | Biomed Chromatogr | Simultaneous determination of thirteen substances related to NAFLD in mouse brain tissue using 3-aminobutyric acid as internal standard by HPLC-FLD. | 2020 | Details |
| A09341 | 31785086 | Obesity (Silver Spring) | Association of Hepatic Global DNA Methylation and Serum One-Carbon Metabolites with Histological Severity in Patients with NAFLD. | 2019 | Details |
| A09342 | 31784293 | Arch Pediatr | Feeding problems and gastrointestinal diseases in Down syndrome. | 2019 | Details |
| A09343 | 31783920 | Syst Rev | Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. | 2019 | Details |
| A09344 | 31783667 | Diagnostics (Basel) | Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion. | 2019 | Details |
| A09345 | 31783635 | Nutrients | Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review. | 2019 | Details |
| A09346 | 31783479 | Int J Mol Sci | Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes. | 2019 | Details |
| A09347 | 31782595 | Liver Int | Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis. | 2019 | Details |
| A09348 | 31782543 | Aliment Pharmacol Ther | The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease. | 2019 | Details |
| A09349 | 31782258 | Physiol Rep | SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model. | 2019 | Details |
| A09350 | 31782176 | Hepatology | Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09351 | 31782025 | Eur J Clin Microbiol Infect Dis | Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection. | 2019 | Details |
| A09353 | 31781899 | Abdom Radiol (NY) | Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity. | 2020 | Details |
| A09354 | 31781248 | Stem Cells Int | Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice. | 2019 | Details |
| A09355 | 31781193 | Gastroenterol Res Pract | Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population. | 2019 | Details |
| A09356 | 31780766 | Sci Rep | Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice. | 2019 | Details |
| A09357 | 31779732 | J Helminthol | Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan City, China. | 2019 | Details |
| A09358 | 31779730 | Br J Nutr | Dietary protein insufficiency: an important consideration in fatty liver disease? | 2019 | Details |
| A09359 | 31779112 | Nutrients | Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? | 2019 | Details |
| A09360 | 31778277 | Pediatr Diabetes | Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. | 2019 | Details |
| A09361 | 31777896 | Food Funct | Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | 2019 | Details |
| A09362 | 31777715 | Pediatr Gastroenterol Hepatol Nutr | New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History. | 2019 | Details |
| A09363 | 31777643 | Int J Physiol Pathophysiol Pharmacol | Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice. | 2019 | Details |
| A09364 | 31777425 | J Clin Biochem Nutr | Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet. | 2019 | Details |
| A09365 | 31776449 | Acta Pharmacol Sin | Serum biomarkers combined with ultrasonography for early diagnosis of non-alcoholic fatty liver disease confirmed by magnetic resonance spectroscopy. | 2019 | Details |
| A09366 | 31776293 | Sci Transl Med | Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis. | 2019 | Details |
| A09367 | 31776016 | Environ Res | Adolescent exposure to environmental level of PCBs (Aroclor 1254) induces non-alcoholic fatty liver disease in male mice. | 2019 | Details |
| A09368 | 31775658 | BMC Gastroenterol | A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels. | 2019 | Details |
| A09369 | 31775341 | Int J Mol Sci | Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. | 2019 | Details |
| A09370 | 33778680 | Radiol Imaging Cancer | Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience. | 2019 | Details |
| A09371 | 31774328 | Expert Rev Gastroenterol Hepatol | The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer. | 2019 | Details |
| A09372 | 31773475 | Eur J Epidemiol | Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study. | 2019 | Details |
| A09373 | 31771682 | Br J Nutr | Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammation. | 2019 | Details |
| A09374 | 31771247 | Genes (Basel) | Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09375 | 31771244 | Nutrients | Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09376 | 31770672 | Mol Ther Nucleic Acids | Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p. | 2019 | Details |
| A09377 | 31770380 | PLoS One | The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women. | 2019 | Details |
| A09378 | 31770351 | Gastroenterol Nurs | Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents: A Cross-Sectional Observational Study. | 2020 | Details |
| A09379 | 31770275 | Medicine (Baltimore) | Association between iron metabolism and cognitive impairment in older non-alcoholic fatty liver disease individuals: A cross-sectional study in patients from a Chinese center. | 2019 | Details |
| A09380 | 31770104 | Eur J Endocrinol | Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. | 2020 | Details |
| A09381 | 31769484 | Clin Sci (Lond) | Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. | 2019 | Details |
| A09382 | 31768801 | J Gastroenterol | Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. | 2019 | Details |
| A09383 | 31767938 | Sci Rep | Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease. | 2019 | Details |
| A09384 | 31767252 | Presse Med | [Pathogenesis of non-alcoholic fatty liver disease]. | 2019 | Details |
| A09385 | 31767251 | Presse Med | [FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients]. | 2019 | Details |
| A09386 | 31766373 | J Clin Med | Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review. | 2019 | Details |
| A09387 | 31765666 | Metabolism | Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults. | 2019 | Details |
| A09389 | 31765354 | Chin Med J (Engl) | Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome. | 2019 | Details |
| A09390 | 31765080 | Liver Int | Cellular endo-lysosomal dysfunction in the pathogenesis of non-alcoholic fatty liver disease. | 2019 | Details |
| A09391 | 31763058 | Am J Cardiovasc Dis | Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome. | 2019 | Details |
| A09392 | 31762620 | Saudi J Biol Sci | Lifestyle interventions for non-alcoholic fatty liver disease. | 2019 | Details |
| A09393 | 31762148 | Liver Int | Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study. | 2019 | Details |
| A09394 | 31761566 | Cell Metab | Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. | 2019 | Details |
| A09395 | 31761548 | Nutr Metab Cardiovasc Dis | Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort. | 2019 | Details |
| A09396 | 31760676 | Intern Med J | Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. | 2020 | Details |
| A09397 | 31760464 | Cell Mol Life Sci | Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. | 2020 | Details |
| A09398 | 31760381 | J Basic Clin Physiol Pharmacol | Development of nonalcoholic fatty liver disease model by high-fat diet in rats. | 2019 | Details |
| A09399 | 31760308 | J Nutr Biochem | Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. | 2019 | Details |
| A09400 | 31760070 | J Hepatol | Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. | 2019 | Details |
| A09401 | 31759197 | J Nutr Biochem | Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise. | 2019 | Details |
| A09402 | 31759125 | Peptides | The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A09403 | 31759065 | Food Chem Toxicol | Baicalein attenuates impairment of hepatic lysosomal acidification induced by high fat diet via maintaining V-ATPase assembly. | 2019 | Details |
| A09404 | 31759057 | Exp Cell Res | Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p. | 2019 | Details |
| A09405 | 31758951 | Metabolism | Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. | 2019 | Details |
| A09407 | 31758699 | Br J Pharmacol | Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice. | 2020 | Details |
| A09408 | 31758647 | Liver Int | Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment. | 2019 | Details |
| A09409 | 31758496 | Clin Transl Oncol | Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). | 2019 | Details |
| A09410 | 31758299 | Rev Endocr Metab Disord | Ghrelin and liver disease. | 2020 | Details |
| A09413 | 31757759 | Mol Ther | HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis. | 2019 | Details |
| A09414 | 31757736 | Presse Med | [What is the position of bariatric surgery in the treatment of non-alcoholic steatohepatitis?] | 2019 | Details |
| A09415 | 31757735 | Presse Med | [Pharmacological treatment of NASH]. | 2019 | Details |
| A09416 | 31757728 | Presse Med | [Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]. | 2019 | Details |
| A09417 | 31757727 | Presse Med | [Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)]. | 2019 | Details |
| A09418 | 31757631 | Nutr Res | Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration. | 2019 | Details |
| A09419 | 31756997 | Metabolites | Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism. | 2019 | Details |
| A09420 | 31756645 | Cytokine | Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population. | 2019 | Details |
| A09421 | 31756344 | Life Sci | Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway. | 2019 | Details |
| A09423 | 31755380 | Curr Pharm Des | Combined use of Genetic Polymorphisms and Elastographic Techniques in NAFLD: Fact or Fiction? | 2020 | Details |
| A09425 | 31754954 | Hormones (Athens) | Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. | 2019 | Details |
| A09426 | 31754293 | World J Gastroenterol | MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. | 2019 | Details |
| A09427 | 31754157 | Sci Rep | The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects. | 2019 | Details |
| A09428 | 31754142 | Sci Rep | New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery. | 2019 | Details |
| A09429 | 31753536 | Mayo Clin Proc | Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. | 2019 | Details |
| A09431 | 31752380 | Diagnostics (Basel) | Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver. | 2019 | Details |
| A09432 | 31752378 | Nutrients | Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? | 2019 | Details |
| A09433 | 31752351 | Nutrients | Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model. | 2019 | Details |
| A09434 | 31752049 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor. | 2019 | Details |
| A09435 | 31751137 | J Med Chem | Discovery of the First Low Nanomolar Liver Receptor Homolog-1 (LRH-1) Agonist. | 2019 | Details |
| A09436 | 31750276 | Front Pediatr | Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children. | 2019 | Details |
| A09437 | 31749914 | Gastroenterol Hepatol Bed Bench | The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider. | 2019 | Details |
| A09438 | 31749901 | World J Hepatol | Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort. | 2019 | Details |
| A09439 | 31749893 | Diabetol Metab Syndr | Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats. | 2019 | Details |
| A09440 | 31749640 | Hepat Med | Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case-Control Study. | 2019 | Details |